Clinical Trial Update: GLP-1 Response and Effect in Individuals With Obesity Causing Genetic Mutations [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating GLP-1 response and effect in individuals with obesity due to genetic mutations; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: University of Copenhagen | Conditions: Obesity | Phase 2 | Status: COMPLETED